TrialSignal
Clinical trial intelligence report
Surgical Management of Diabetic Foot Infections - The Role of Post-Operative Antibiotics
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT01539811-Jul 28, 2026
NCT ID
NCT01539811
Status
TERMINATED
Phase
NA
Sponsor
Prisma Health-Upstate
Executive brief
Investment-Ready Snapshot
Surgical Management of Diabetic Foot Infections
The Role of Post-Operative Antibiotics is a NA clinical asset sponsored by Prisma Health-Upstate in Diabetic Foot Infections. SEO and diligence focus: Surgical incision and drainage of diabetic foot infection, Short course antibiotics, Long course antibiotics, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01539811
Indication
Diabetic Foot Infections
Modality
small molecule
Target
Surgical incision and drainage of diabetic foot infection, Short course antibiotics, Long course antibiotics
Intervention
Surgical incision and drainage of diabetic foot infection, Short course antibiotics, Long course antibiotics
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.